Cognitive Decline 1. Study: “Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders" (2021) o Findings: MSCs protect neurons, promote neurogenesis, reduce brain inflammation, and enhance memory function in aging models. o Source: MDPI 2. Study: "Intravenous Stem Cell Therapy for Age-Related Cognitive Decline" (2019) o Findings: MSC infusions improve memory, reduce neuroinflammation, and enhance cognitive performance in clinical trials.
o Source: Journal of Neuroinflammation
3. Study: "Intravenous infusion of mesenchymal stem cells improves cognitive function and reduces amyloid-beta deposition in a transgenic mouse model of Alzheimer's disease." o Findings: MSCs improve cognitive function and reduce pathological features of Alzheimer's disease.
Source: Frontiers
o
Hearing Loss 1. Study: "Mesenchymal stem cell transplantation accelerates hearing recovery through the repair of injured cochlear fibrocytes." o Findings: MSCs repair cochlear cells, improving auditory function after damage or degeneration.
o Source: The American Journal of Pathology
Cataracts & AMD
• Study: "Mesenchymal stem cells promote the retinal ganglion cell survival and axon regeneration after optic nerve injury." o Findings: MSCs help protect and regenerate retinal cells, showing promise for AMD and cataracts. Source: PubMed
© 2024 Longevity Medical Institute. All rights reserved.
10
Made with FlippingBook Annual report maker